046210 — HLB PanaGene Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapNeutral

Annual balance sheet for HLB PanaGene Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	17,611	19,947	76,852	60,932	33,777
Net Total Accounts Receivable
Net Total Receivables	2,510	2,795	3,004	4,309	4,864
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	23,444	26,014	82,900	69,445	42,264
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	7,298	7,029	7,338	14,276	16,099
Net Goodwill
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	31,909	34,673	90,914	109,611	92,936
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	794	1,419	27,134	28,693	18,703
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	2,066	2,984	27,341	33,567	20,587
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	29,844	31,689	63,573	76,043	72,350
Total Liabilities & Shareholders' Equity	31,909	34,673	90,914	109,611	92,936
Total Common Shares Outstanding